Literature DB >> 8858915

Identification of an octamer-1 transcription factor binding site in the promoter of the mouse mu-opioid receptor gene.

Y Liang1, L G Carr.   

Abstract

In a previous study we showed that a region from -182 to +10 bp in the mouse mu-opioid receptor (MOR) promoter exhibited strong promoter activity. To identify protein-DNA interactions in this fragment, gel shift and DNase I footprint analyses were performed using nuclear extracts from mouse brain and the human neuroblastoma cell line, SK-N-SH. Two regions, nucleotide (nt) -121 to -100 and nt -42 to -22, were identified as being specific protein binding sites. The protein-DNA interaction in the nt -42 to -22 region was characterized in detail in this study. Methylation interference analysis of this region showed that nuclear protein from SK-N-SH cells contracted nucleotides within the sequence ATG-CAAAT, which is a binding motif for octamer trans-acting factors. An octamer-1 (Oct-1)-specific antibody super-shifted the protein-DNA complex in a gel shift assay. A UV cross-linking experiment showed that a nuclear protein, whose molecular weight is similar to that of the Oct-1 factor, bound to the octamer element in the nt -42 to -22 region. Mutagenesis of four base pairs within the octamer cis-acting element eliminated the specific protein binding in vitro. When the MOR-luciferase reporter construct (-182 to +10 bp) with the same four base pairs mutated was transiently transfected into SK-N-SH cells, a 200% increase in transcriptional activity was observed. Collectively, these data suggest that Oct-1 is binding to the octamer motif in the MOR gene and negatively modulating MOR gene expression.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8858915     DOI: 10.1046/j.1471-4159.1996.67041352.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  7 in total

Review 1.  Transcriptional and epigenetic regulation of opioid receptor genes: present and future.

Authors:  Li-Na Wei; Horace H Loh
Journal:  Annu Rev Pharmacol Toxicol       Date:  2011       Impact factor: 13.820

Review 2.  Mu opioids and their receptors: evolution of a concept.

Authors:  Gavril W Pasternak; Ying-Xian Pan
Journal:  Pharmacol Rev       Date:  2013-09-27       Impact factor: 25.468

3.  Up-regulation of the mu-opioid receptor gene is mediated through chromatin remodeling and transcriptional factors in differentiated neuronal cells.

Authors:  Cheol Kyu Hwang; Chun Sung Kim; Do Kyung Kim; Ping-Yee Law; Li-Na Wei; Horace H Loh
Journal:  Mol Pharmacol       Date:  2010-04-12       Impact factor: 4.436

4.  Inhibition of c-Jun NH2-terminal kinase stimulates mu opioid receptor expression via p38 MAPK-mediated nuclear NF-κB activation in neuronal and non-neuronal cells.

Authors:  Yadav Wagley; Cheol Kyu Hwang; Hong-Yiou Lin; Angel F Y Kam; Ping-Yee Law; Horace H Loh; Li-Na Wei
Journal:  Biochim Biophys Acta       Date:  2013-02-26

5.  A novel transcription mechanism activated by ethanol: induction of Slc7a11 gene expression via inhibition of the DNA-binding activity of transcriptional repressor octamer-binding transcription factor 1 (OCT-1).

Authors:  Xinghua Lin; Hong Yang; Hongfeng Zhang; LiChun Zhou; ZhongMao Guo
Journal:  J Biol Chem       Date:  2013-04-16       Impact factor: 5.157

6.  Characterizing exons 11 and 1 promoters of the mu opioid receptor (Oprm) gene in transgenic mice.

Authors:  Jin Xu; Mingming Xu; Ying-Xian Pan
Journal:  BMC Mol Biol       Date:  2006-11-13       Impact factor: 2.946

Review 7.  Epigenetic Modulation of Opioid Receptors by Drugs of Abuse.

Authors:  Ke Zhang Reid; Brendan Matthew Lemezis; Tien-Chi Hou; Rong Chen
Journal:  Int J Mol Sci       Date:  2022-10-05       Impact factor: 6.208

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.